The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of PSA-tricom, a pox-viral vaccine in prostate cancer (PCa), on tumor growth rates within 80 days after initiation in nonmetastatic PCa.
James L. Gulley
No relevant relationships to disclose
Ravi Amrit Madan
No relevant relationships to disclose
Wilfred Donald Stein
No relevant relationships to disclose
Julia Wilkerson
No relevant relationships to disclose
Antonio Fojo
No relevant relationships to disclose
William L. Dahut
No relevant relationships to disclose
Christopher Ryan Heery
No relevant relationships to disclose
Susan Bates
No relevant relationships to disclose
Jeffrey Schlom
Research Funding - Bavarian Nordic
George Wilding
No relevant relationships to disclose
Robert S. DiPaola
No relevant relationships to disclose
Judith Manola
No relevant relationships to disclose